Buy Tesamorelin UK

When a laboratory orders Tesamorelin for in-vitro research, two things decide whether the work is reproducible: knowing what is actually in the vial, and getting it onto the bench still intact. Every batch we hold is verified at 99%+ purity by HPLC, and the measured figure for the specific lot you receive is printed on its batch Certificate of Analysis — not a generic spec sheet. That COA ships with the order, and recent ones are kept in the on-site COA library so you can check a batch before you buy. Because peptides are temperature-sensitive, stock is handled cold-chain through to dispatch. Orders confirmed before the daily cut-off leave a UK facility the same working day on tracked next-working-day delivery. Wholesale and repeat-supply enquiries are handled through our trade desk. Everything we supply is for in-vitro laboratory research only.

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH 1-44). In the research literature it is described as a stabilised GHRH peptide: the native 44-amino-acid sequence is modified at the N-terminus, a structural feature most often cited when it is compared with shorter GHRH fragments. As a member of the secretagogue family, it is described in the published literature as a subject of study in laboratory models examining the GHRH receptor signalling pathway. Investigations reported in that literature typically look at receptor binding, downstream signalling and the in-vitro behaviour of the modified sequence relative to unmodified GHRH.

All of this is research context only. Tesamorelin is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, not for diagnostic use, and not for any therapeutic purpose. We make no claims about effects in humans; the points above summarise how the compound is characterised in the scientific literature, not outcomes you should expect. Researchers should consult primary sources and design their own controls.

Tesamorelin and CJC-1295 are often grouped together in the literature because both are GHRH-based, but they are structurally distinct and that distinction matters when designing a study. Tesamorelin is a stabilised analogue of the full GHRH 1-44 sequence. CJC-1295, by contrast, is built on the shorter GHRH 1-29 fragment, and is described in two forms in the literature — with and without the DAC (drug-affinity complex) modification. Choosing between them is a function of the sequence and modification your protocol calls for, so the batch COA is the document to read first: it states the identity and the HPLC-measured purity for the exact lot.

Every vial we dispatch is traceable to a batch verified at 99%+ purity by HPLC, with that lot's COA included in the package and mirrored in the on-site COA library. Material is stored and shipped cold-chain because peptides are temperature-sensitive. If you need ongoing or larger-volume supply for a research programme, the trade desk handles wholesale terms. All material is supplied for in-vitro laboratory research only.